From Casetext: Smarter Legal Research

Avanir Pharms. Inc. v. Par Pharm. Inc.

United States Court of Appeals for the Federal Circuit
Aug 10, 2015
612 F. App'x 613 (Fed. Cir. 2015)

Opinion

2014-1838

08-10-2015

AVANIR PHARMACEUTICALS INC., Plaintiff-Appellee AVANIR HOLDING COMPANY, CENTER FOR NEUROLOGICAL STUDY, Plaintiffs v. PAR PHARMACEUTICAL INC., PAR PHARMACEUTICAL COMPANIES INC., Defendants-Appellants

F. DOMINIC CERRITO, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for plaintiff-appellee. Also represented by ERIC C. STOPS, EVANGELINE SHIH, DANIEL C. WIESNER. JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, argued for defendants-appellants. Also represented by RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO ANDERSON, STEPHEN YANG.


NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the District of Delaware in No. 1:11-cv-00704-LPS, Chief Judge Leonard P. Stark.

JUDGMENT

F. DOMINIC CERRITO, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for plaintiff-appellee. Also represented by ERIC C. STOPS, EVANGELINE SHIH, DANIEL C. WIESNER. JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, argued for defendants-appellants. Also represented by RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO ANDERSON, STEPHEN YANG. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (CHEN, LINN, and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT August 10, 2015

Date

/s/ Daniel E. O'Toole

Daniel E. O'Toole

Clerk of Court


Summaries of

Avanir Pharms. Inc. v. Par Pharm. Inc.

United States Court of Appeals for the Federal Circuit
Aug 10, 2015
612 F. App'x 613 (Fed. Cir. 2015)
Case details for

Avanir Pharms. Inc. v. Par Pharm. Inc.

Case Details

Full title:AVANIR PHARMACEUTICALS INC., Plaintiff-Appellee AVANIR HOLDING COMPANY…

Court:United States Court of Appeals for the Federal Circuit

Date published: Aug 10, 2015

Citations

612 F. App'x 613 (Fed. Cir. 2015)

Citing Cases

Janssen Pharm. v. Tolmar, Inc.

“[W]here a problem was not known in the art, the solution to that problem may not be obvious, because…

Bayer Pharma AG v. Watson Labs., Inc.

Galderma may extend to cases in which "the prior art does not teach [the] particular combination of amounts…